The UK healthcare sector is undergoing a digital transformation, with Electronic Patient Records (EPRs) systems at the heart of this shift. EPRs have become essential tools for improving care coordination, reducing administrative burdens and enhancing overall efficiency in the NHS.
As the demand for digital solutions intensifies, particularly in light of the NHS’ 2025 deadline for 100% EPR adoption, the market presents a significant growth opportunity for investors and acquirers. As a result, the sector has attracted considerable M&A activity across EPRs and complementary modular solutions.
Several deals have been centred around specialist systems, including YFM-backed DrDoctor’s acquisition of Maia (a mental health-focused personal health record platform), Abingdon Software’s acquisition of Cambric Systems (EPR solutions for community staff) and System C’s acquisition of Clevermed (a maternity-focused EPR system).
Alongside these niche transactions, the sector has seen mega deals for its key players, including Oracle’s acquisition of Cerner (the most widely used EPR in NHS Trusts), and United Health’s acquisition of EMIS (the primary care specialist).
Private equity investors are also actively backing companies in this space. Mayden, for example, has partnered with G Square to expand its leading EPR platform, iaptus, which serves mental health services across the UK. The investment, which will support the company in its plans to expand market reach both domestically and internationally, serves as an illustration of the growth opportunities seen in the sector by private equity.
The UK EPR market is ripe for further M&A and investment activity as more NHS Trusts and healthcare providers seek to upgrade their digital infrastructure. As demand for interoperable, cloud-based solutions continues to grow, investors are looking to capitalise on the sector’s potential for long-term, recurring revenue streams. The ongoing digital transformation in healthcare will likely drive more consolidation and innovation in the coming years, making it a compelling investment opportunity for those seeking exposure to the evolving healthcare tech landscape.
Comments